Overview
Kaposiform lymphangiomatosis (KLA) is a very rare disorder of the lymphatic system, which is the network of vessels and tissues that helps your body fight infection and maintain fluid balance. In KLA, abnormal lymphatic tissue grows in an uncontrolled way and spreads through multiple organs, most commonly the lungs, bones, spleen, and the mediastinum (the area between the lungs). Unlike some other lymphatic malformations that stay in one spot, KLA tends to involve many parts of the body at once. The abnormal tissue has a distinctive appearance under the microscope, with spindle-shaped cells that resemble those seen in another condition called kaposiform hemangioendothelioma, which is how it got its name. Key symptoms include fluid collections around the lungs (pleural effusions) and around the heart (pericardial effusions), bleeding problems, bone pain or bone destruction, abdominal swelling, and breathing difficulties. Many patients develop a serious bleeding complication called consumptive coagulopathy, where the body uses up clotting factors faster than it can make them. This can lead to dangerous bleeding episodes. Treatment for KLA is challenging because there is no cure. The drug sirolimus (also known as rapamycin), which targets the mTOR pathway, has become the most widely used treatment and can help slow disease progression and reduce symptoms in many patients. Other treatments may include drainage of fluid collections, supportive care for bleeding problems, and sometimes chemotherapy-like drugs such as vincristine. Despite treatment, KLA can be life-threatening, especially when it involves the lungs or causes severe bleeding complications.
Key symptoms:
Fluid buildup around the lungs (pleural effusion)Fluid buildup around the heart (pericardial effusion)Difficulty breathing or shortness of breathBleeding problems or easy bruisingBone pain or bone lesionsAbdominal swelling or fluid in the bellyEnlarged spleenLow platelet countsCoughing up bloodFatigue and weaknessChest painSwelling in the arms, legs, or other body partsRecurrent infectionsLow blood protein levels
Clinical phenotype terms (46)— hover any for plain English
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Kaposiform lymphangiomatosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Kaposiform lymphangiomatosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Kaposiform lymphangiomatosis.
Community
No community posts yet. Be the first to share your experience with Kaposiform lymphangiomatosis.
Start the conversation →Latest news about Kaposiform lymphangiomatosis
No recent news articles for Kaposiform lymphangiomatosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which organs are affected in my case, and how severe is the involvement?,Is sirolimus the right treatment for me, and what side effects should I watch for?,How often will I need blood tests and imaging to monitor the disease?,What are the warning signs that I should go to the emergency room?,Are there any clinical trials or new treatments available for KLA?,Should I be seen at a specialized vascular anomalies center?,What activity restrictions should I follow to reduce bleeding risk?
Common questions about Kaposiform lymphangiomatosis
What is Kaposiform lymphangiomatosis?
Kaposiform lymphangiomatosis (KLA) is a very rare disorder of the lymphatic system, which is the network of vessels and tissues that helps your body fight infection and maintain fluid balance. In KLA, abnormal lymphatic tissue grows in an uncontrolled way and spreads through multiple organs, most commonly the lungs, bones, spleen, and the mediastinum (the area between the lungs). Unlike some other lymphatic malformations that stay in one spot, KLA tends to involve many parts of the body at once. The abnormal tissue has a distinctive appearance under the microscope, with spindle-shaped cells th
How is Kaposiform lymphangiomatosis inherited?
Kaposiform lymphangiomatosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Kaposiform lymphangiomatosis?
5 specialists and care centers treating Kaposiform lymphangiomatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.